Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[bhp1rtp]

Compassionate Use

Contrary to widespread perception, the U.S. Food and Drug Administration (FDA) is not an obstacle to those seeking compassionate use. In fact, the FDA almost always defers to the company that is developing the unapproved treatment to decide whether to grant compassionate use access

http://www.newswise.com/articles/b-compassionate-use-and-other-means-of-accessing-unproven-and-unapproved-treatments-could-impact-long-term-medical-benefits-b?ret=/articles/list&category=medicine&page=1&search[status]=3&search[sort]=date+desc&search[section]=10&search[has_multimedia]=